Pages that link to "Q50556656"

The following pages link to The M1 Muscarinic Positive Allosteric Modulator PQCA Improves Performance on Translatable Tests of Memory and Attention in Rhesus Monkeys (Q50556656):

Displaying 23 items.

• M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss (Q34547610) (← links)
• Characterization of a Novel M1 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator Radioligand, [3H]PT-1284. (Q38759673) (← links)
• Non human primate models for Alzheimer's disease-related research and drug discovery (Q38783343) (← links)
• Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders (Q39284158) (← links)
• Emerging amyloid and tau targeting treatments for Alzheimer's disease (Q39296311) (← links)
• Emerging treatments for Alzheimer's disease for non-amyloid and non-tau targets. (Q39296351) (← links)
• Scopolamine Induces Deficits in Spontaneous Object-Location Recognition and Fear-Learning in Marmoset Monkeys (Q41081003) (← links)
• Cholinergic Regulation of hnRNPA2/B1 Translation by M1 Muscarinic Receptors. (Q42494378) (← links)
• Molecular mechanisms of serotonergic action of the HIV-1 antiretroviral efavirenz (Q42592784) (← links)
• Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning (Q47158626) (← links)
• Positive allosteric modulation of M1 and M4 muscarinic receptors as potential therapeutic treatments for schizophrenia (Q48001582) (← links)
• Preferential cholinergic excitation of corticopontine neurons. (Q48250039) (← links)
• Functional Characterization of Acetylcholine Receptors Expressed in Human Neurons Differentiated from Hippocampal Neural Stem/Progenitor Cells (Q48544344) (← links)
• A novel M1 PAM VU0486846 exerts efficacy in cognition models without displaying agonist activity or cholinergic toxicity. (Q52558952) (← links)
• In vitro pharmacological characterization and in vivo validation of LSN3172176 a novel M1 selective muscarinic receptor agonist tracer molecule for positron emission tomography (PET). (Q52593214) (← links)
• Prediction of consensus binding mode geometries for related chemical series of positive allosteric modulators of adenosine and muscarinic acetylcholine receptors. (Q52737158) (← links)
• Bitopic Binding Mode of an M1 Muscarinic Acetylcholine Receptor Agonist Associated with Adverse Clinical Trial Outcomes. (Q55209075) (← links)
• Identification and pharmacological profile of SPP1, a potent, functionally selective and brain penetrant M1 muscarinic acetylcholine receptor agonist (Q57052929) (← links)
• M-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognition (Q59221232) (← links)
• TAK-071, a muscarinic M1 receptor positive allosteric modulator, attenuates scopolamine-induced quantitative electroencephalogram power spectral changes in cynomolgus monkeys (Q64109469) (← links)
• Roles of the M4 acetylcholine receptor in the basal ganglia and the treatment of movement disorders (Q64759887) (← links)
• VU6007477, a Novel M1 PAM Based on a Pyrrolo[2,3-b]pyridine Carboxamide Core Devoid of Cholinergic Adverse Events (Q91789039) (← links)
• T-495, a novel low cooperative M1 receptor positive allosteric modulator, improves memory deficits associated with cholinergic dysfunction and is characterized by low gastrointestinal side effect risk (Q92992706) (← links)